Back to Search
ABDELSALAM SHARABI, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1922043850IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
234557(NY)
Hematology (Pathology) Physician
Pathology — Hematology
Code: 207ZH0000X
234557(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1989
Research & Publications (20)
Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
PMID 19596183·J Autoimmun·2010
7-preclinical
Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products.
PMID 19544467·Stem Cells·2009
7-preclinical
A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice.
PMID 19631585·Clin Immunol·2009
7-preclinical
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.
PMID 19346102·J Autoimmun·2009
8-other
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.
PMID 19280712·Hum Immunol·2009
8-other
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
PMID 19188092·Clin Immunol·2009
7-preclinical
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.
PMID 19040426·Immunology·2009
7-preclinical
A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action.
PMID 18300570·Isr Med Assoc J·2008
6-review
The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
PMID 18713995·J Immunol·2008
7-preclinical
Altered gene expression in mice with lupus treated with edratide, a peptide that ameliorates the disease manifestations.
PMID 17599765·Arthritis Rheum·2007
7-preclinical
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.
PMID 17956982·Proc Natl Acad Sci U S A·2007
7-preclinical
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model.
PMID 17911582·J Immunol·2007
7-preclinical
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action.
PMID 17346282·Immunology·2007
4-observational
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta.
PMID 16735466·Proc Natl Acad Sci U S A·2006
7-preclinical
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosis.
PMID 16503419·Clin Immunol·2006
4-observational
Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase.
PMID 16257268·Clin Immunol·2005
7-preclinical
Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain.
PMID 15525652·J Biol Chem·2005
7-preclinical
Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts.
PMID 15020672·J Cell Sci·2004
4-observational
Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology.
PMID 14688206·FASEB J·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 NATHAN D PERLMAN PLACE, SUITE 12S34
NEW YORK, NY 10003 - Phone
- (212) 420-2124
Quick Facts
- NPI
- 1922043850
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile